We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Accelerating target discovery using pre-competitive open science-patients need faster innovation more than anyone else.
- Authors
Low, Eric; Bountra, Chas; Lee, Wen Hwa
- Abstract
We are experiencing a new era enabled by unencumbered access to high quality data through the emergence of open science initiatives in the historically challenging area of early stage drug discovery. At the same time, many patient-centric organisations are taking matters into their own hands by participating in, enabling and funding research. Here we present the rationale behind the innovative partnership between the Structural Genomics Consortium (SGC)-an open, pre-competitive pre-clinical research consortium and the research-focused patient organisation Myeloma UK to create a new, comprehensive platform to accelerate the discovery and development of new treatments for multiple myeloma. For anyone involved in biomedicine, especially in oncology, it seems like every other day we hear reports in the media about a new wonder drug or a potential cure. What is more, when scientists and clinicians attend conferences and read research journals, there is a seemingly endless amount of data being presented on the results of research, but still progress towards finding cures seems painfully slow. Why is this? One reason could be that the research or trials being done are on the same tired handful of targets and mechanisms.
- Subjects
DRUG development; MEDICAL research; THERAPEUTICS research; ONCOLOGY; CLINICAL trials
- Publication
Ecancermedicalscience, 2016, Vol 10, Issue 651-673, p1
- ISSN
1754-6605
- Publication type
Article
- DOI
10.3332/ecancer.2016.ed57